336 related articles for article (PubMed ID: 34289344)
21. Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans.
Xue X; Shi J; Xu H; Qin Y; Yang Z; Feng S; Liu D; Jian L; Hua L; Wang Y; Zhang Q; Huang X; Zhang X; Li X; Chen C; Guo J; Tang W; Liu J
Sci Rep; 2021 Feb; 11(1):3187. PubMed ID: 33542420
[TBL] [Abstract][Full Text] [Related]
22. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
23. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
24. Comparative genetic analyses of Korean bat coronaviruses with SARS-CoV and the newly emerged SARS-CoV-2.
Na EJ; Lee SY; Kim HJ; Oem JK
J Vet Sci; 2021 Jan; 22(1):e12. PubMed ID: 33522164
[TBL] [Abstract][Full Text] [Related]
25. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus.
Sheahan T; Rockx B; Donaldson E; Corti D; Baric R
J Virol; 2008 Sep; 82(17):8721-32. PubMed ID: 18579604
[TBL] [Abstract][Full Text] [Related]
26. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochem Biophys Res Commun; 2021 Jan; 534():374-380. PubMed ID: 33272568
[TBL] [Abstract][Full Text] [Related]
27. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2
Li Z; Zhang JZH
Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759
[TBL] [Abstract][Full Text] [Related]
29. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
[TBL] [Abstract][Full Text] [Related]
30. A novel SARS-CoV-2 related coronavirus in bats from Cambodia.
Delaune D; Hul V; Karlsson EA; Hassanin A; Ou TP; Baidaliuk A; Gámbaro F; Prot M; Tu VT; Chea S; Keatts L; Mazet J; Johnson CK; Buchy P; Dussart P; Goldstein T; Simon-Lorière E; Duong V
Nat Commun; 2021 Nov; 12(1):6563. PubMed ID: 34753934
[TBL] [Abstract][Full Text] [Related]
31. A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
Liu MQ; Lin HF; Li J; Chen Y; Luo Y; Zhang W; Hu B; Tian FJ; Hu YJ; Liu YJ; Jiang RD; Gong QC; Li A; Guo ZS; Li B; Yang XL; Tong YG; Shi ZL
J Virol; 2023 Feb; 97(2):e0171922. PubMed ID: 36688655
[TBL] [Abstract][Full Text] [Related]
32. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
Johnson BA; Xie X; Bailey AL; Kalveram B; Lokugamage KG; Muruato A; Zou J; Zhang X; Juelich T; Smith JK; Zhang L; Bopp N; Schindewolf C; Vu M; Vanderheiden A; Winkler ES; Swetnam D; Plante JA; Aguilar P; Plante KS; Popov V; Lee B; Weaver SC; Suthar MS; Routh AL; Ren P; Ku Z; An Z; Debbink K; Diamond MS; Shi PY; Freiberg AN; Menachery VD
Nature; 2021 Mar; 591(7849):293-299. PubMed ID: 33494095
[TBL] [Abstract][Full Text] [Related]
33. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
Jackson CB; Zhang L; Farzan M; Choe H
Biochem Biophys Res Commun; 2021 Jan; 538():108-115. PubMed ID: 33220921
[TBL] [Abstract][Full Text] [Related]
34. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
35. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2.
Celik I; Khan A; Dwivany FM; Fatimawali ; Wei DQ; Tallei TE
Mol Divers; 2022 Dec; 26(6):3309-3324. PubMed ID: 35138508
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic.
Rostami N; Choupani E; Hernandez Y; Arab SS; Jazayeri SM; Gomari MM
J Cell Biochem; 2022 Feb; 123(2):417-430. PubMed ID: 34783057
[TBL] [Abstract][Full Text] [Related]
37. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
38. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
[TBL] [Abstract][Full Text] [Related]
39. Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.
Luan B; Wang H; Huynh T
FEBS Lett; 2021 May; 595(10):1454-1461. PubMed ID: 33728680
[TBL] [Abstract][Full Text] [Related]
40. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
